Systematic discovery of germline cancer predisposition genes through the identification of somatic second hits

被引:42
作者
Park, Solip [1 ]
Supek, Fran [1 ,2 ,3 ]
Lehner, Ben [1 ,4 ,5 ]
机构
[1] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, Syst Biol Program, Dr Aiguader 88, Barcelona 08003, Spain
[2] Barcelona Inst Sci & Technol, Inst Recerca Biomed IRB Barcelona, Barcelona 08028, Spain
[3] Rudjer Boskovic Inst, Div Elect, Zagreb 10000, Croatia
[4] UPF, Barcelona 08003, Spain
[5] ICREA, Pg Luis Co 23, Barcelona 08010, Spain
基金
欧洲研究理事会;
关键词
MUTATIONS; VARIANTS; PATTERNS; NSD1; RARE; HAPLOINSUFFICIENCY; HETEROGENEITY; INACTIVATION; HEALTH; DRIVE;
D O I
10.1038/s41467-018-04900-7
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The genetic causes of cancer include both somatic mutations and inherited germline variants. Large-scale tumor sequencing has revolutionized the identification of somatic driver alterations but has had limited impact on the identification of cancer predisposition genes (CPGs). Here we present a statistical method, ALFRED, that tests Knudson's two-hit hypothesis to systematically identify CPGs from cancer genome data. Applied to similar to 10,000 tumor exomes the approach identifies known and putative CPGs - including the chromatin modifier NSD1 - that contribute to cancer through a combination of rare germline variants and somatic loss-of-heterozygosity (LOH). Rare germline variants in these genes contribute substantially to cancer risk, including to similar to 14% of ovarian carcinomas, similar to 7% of breast tumors, similar to 4% of uterine corpus endometrial carcinomas, and to a median of 2% of tumors across 17 cancer types.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Pathogenic germline variants in SMARCA4 and further cancer predisposition genes in early onset ovarian cancer
    Herold, Natalie
    Schmolling, Johanna
    Ernst, Corinna
    Ataseven, Beyhan
    Bluemcke, Britta
    Schoemig-Markiefka, Birgid
    Heikaus, Sebastian
    Goehring, Uwe-Jochen
    Engel, Christoph
    Lampe, Bjoern
    Rhiem, Kerstin
    Harter, Philipp
    Hauke, Jan
    Schmutzler, Rita K.
    Hahnen, Eric
    CANCER MEDICINE, 2023, 12 (14): : 15256 - 15260
  • [22] Contribution of germline mutations in cancer predisposition genes to tumor etiology in young women diagnosed with invasive breast cancer
    Rummel, Seth K.
    Lovejoy, Leann
    Shriver, Craig D.
    Ellsworth, Rachel E.
    BREAST CANCER RESEARCH AND TREATMENT, 2017, 164 (03) : 593 - 601
  • [23] Prevalence of pathogenic or likely pathogenic germline variants in cancer predisposition genes among selected patients with lung adenocarcinoma: The GERMLUNG study
    Arrieta, Oscar
    Caballe-Perez, Enrique
    Hernandez-Pedro, Norma
    Romero-Nunez, Eunice
    Lucio-Lozada, Jose
    Castillo-Ruiz, Cesar
    Acevedo-Castillo, Karla
    Alvarez-Gomez, Rosa Maria
    Molina-Garay, Carolina
    Jimenez-Olivares, Marco
    Carrillo-Sanchez, Karol
    Mendoza-Caamal, Elvia Cristina
    Cardona, Andres F.
    Remon, Jordi
    Alaez-Verson, Carmen
    LUNG CANCER, 2024, 194
  • [24] Somatic tumor mutations in moderate risk cancer genes: Targets for germline confirmatory testing
    Llorin, Hannah
    Graf, Madeline
    Chun, Nicolette
    Ford, James
    CANCER GENETICS, 2022, 268 : 22 - 27
  • [25] Identification of mutations in cancer predisposition genes in radiosensitive and radioresistant patients with nasopharyngeal carcinoma
    Wang, Xingwen
    Wu, Yunyan
    Li, Qiang
    Lv, Dongxiao
    Han, Junqing
    Liu, Ping
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (18): : 8128 - 8133
  • [26] Systematic identification of novel cancer genes through analysis of deep shRNA perturbation screens
    Montazeri, Hesam
    Coto-Llerena, Mairene
    Bianco, Gaia
    Zangene, Ehsan
    Taha-Mehlitz, Stephanie
    Paradiso, Viola
    Srivatsa, Sumana
    de Weck, Antoine
    Roma, Guglielmo
    Lanzafame, Manuela
    Bolli, Martin
    Beerenwinkel, Niko
    von Fluee, Markus
    Terracciano, Luigi M.
    Piscuoglio, Salvatore
    Ng, Charlotte K. Y.
    NUCLEIC ACIDS RESEARCH, 2021, 49 (15) : 8488 - 8504
  • [27] Optimizing Ovarian Cancer Treatment and Prevention Through Parallel Germline and Somatic Genetic Testing
    Kwon, Janice S.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2024, 22 (2D):
  • [28] Germline and somatic mutations of homologous recombination-associated genes in Japanese ovarian cancer patients
    Sugino, Kentaro
    Tamura, Ryo
    Nakaoka, Hirofumi
    Yachida, Nozomi
    Yamaguchi, Manako
    Mori, Yutaro
    Yamawaki, Kaoru
    Suda, Kazuaki
    Ishiguro, Tatsuya
    Adachi, Sosuke
    Isobe, Masanori
    Yamaguchi, Masayuki
    Kashima, Katsunori
    Motoyama, Teiichi
    Inoue, Ituro
    Yoshihara, Kosuke
    Enomoto, Takayuki
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [29] Prevalence of Germline Mutations in Cancer Predisposition Genes in Patients with Pancreatic Cancer or Suspected Related Hereditary Syndromes: Historical Prospective Analysis
    Dal Buono, Arianna
    Poliani, Laura
    Greco, Luana
    Bianchi, Paolo
    Barile, Monica
    Giatti, Valentina
    Bonifacio, Cristiana
    Carrara, Silvia
    Malesci, Alberto
    Laghi, Luigi
    CANCERS, 2023, 15 (06)
  • [30] Primer on Hereditary Cancer Predisposition Genes Included Within Somatic Next-Generation Sequencing Panels
    Akras, Zade
    Bungo, Brandon
    Leach, Brandie H.
    Marquard, Jessica
    Ahluwalia, Manmeet
    Carraway, Hetty
    Grivas, Petros
    Sohal, Davendra P. S.
    Funchain, Pauline
    JCO PRECISION ONCOLOGY, 2019, 3 : 1 - 11